REGN Regeneron Pharmaceuticals, Inc.

Pharmaceutical Preparations · Nasdaq · SEC EDGAR official

Market Value*

$54.80B

Revenue (FY)

$14.34B 2025-12-31

Net Income (FY)

$4.50B

P/E (float-based)

12.2

scholarly article.

Financial History annual

Interactive chart · SEC EDGAR annual filings (10-K / 20-F) · enable JavaScript if blank

*Market value = public float disclosed in latest 10-K filing · CIK 872589 · SEC filings · revenue ranking · home